Nombre del producto:tert-Butyl trichloroacetimidate

IUPAC Name:tert-butyl 2,2,2-trichloroethanimidate

CAS:98946-18-0
Fórmula molecular:C6H10Cl3NO
Pureza:97%
Número de catálogo:CM256074
Peso molecular:218.5

Unidad de embalaje Stock disponible Precio($) Cantidad
CM256074-500g in stock ƏşǺ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :98946-18-0
Fórmula molecular:C6H10Cl3NO
Punto de fusión:-
Código de sonrisas:CC(OC(C(Cl)(Cl)Cl)=N)(C)C
Densidad:
Número de catálogo:CM256074
Peso molecular:218.5
Punto de ebullición:183.3°C at 760 mmHg
Nº Mdl:MFCD00077410
Almacenamiento:Keep in a tight container and store at below -20°C

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

Column Infos

Vepdegestrant
Arvinas and Pfizer updated clinical data from a Phase 1b combination cohort evaluating vepdegestrant in combination with palbociclib. These data show that vepdegestrant plus palbociclib continue to demonstrate encouraging clinical activity in heavily pre-treated patients with a median of four lines of prior therapy with locally advanced or metastatic ER positive/human epidermal growth factor 2 – HER2 – negative breast cancer. Vepdegestrant is an investigational PROTAC ER degrader designed to harness the body’s natural protein disposal system to specifically target and degrade the estrogen receptor.

Related Products